FDA.reportPublic FDA data

tenofovir alafenamide 25 MG Oral Tablet [Vemlidy]

RxCUI
1858267
RxNorm name
tenofovir alafenamide 25 MG Oral Tablet [Vemlidy]
Display name
tenofovir alafenamide 25 MG Oral Tablet [Vemlidy]
Full name
tenofovir alafenamide 25 MG Oral Tablet [Vemlidy]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VEMLIDYTENOFOVIR ALAFENAMIDEGilead Sciences, Inc.72e6b33c-0351-4070-9172-eeaa186c01d22025-07-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1858267

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
72e6b33c-0351-4070-9172-eeaa186c01d2Vemlidy 25 MG Oral Tablet [PSN] · tenofovir alafenamide 25 MG Oral Tablet [Vemlidy] [SBD] · Vemlidy 25 MG (equiv. to 28 MG tenofovir alafenamide fumarate) Oral Tablet [SY] · Vemlidy 25 MG Oral Tablet [SY]417These highlights do not include all the information needed to use VEMLIDY safely and effectively. See full prescribing information for VEMLIDY. VEMLIDY ® (tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 201520250714